Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31145340 | 0.98 | HSD17B10 (0.43) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL13108263 | 0.90 | HSD17B10 (0.52) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL17803793 | 0.87 | HSD17B10 (0.50) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL7901287 | 0.87 | HSD17B10 (0.44) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL13108266 | 0.87 | HSD17B10 (0.50) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL18352863 | 0.87 | USP2 (0.44) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL8263940 | 0.85 | HSD17B10 (0.42) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL9999939 | 0.85 | HSD17B10 (0.42) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL6989580 | 0.85 | HSD17B10 (0.42) | HSD17B10USP2HTTLPAR5TDP1 | |
| SCHEMBL27220429 | 0.85 | HSD17B10 (0.42) | HSD17B10USP2HTTLPAR5TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118048210-A | Detergent composition | 广州立白企业集团有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-11639413-B2 | Polymerizable composition for optical materials and application of same | MITSUI CHEMICALS, INC. (JP) | 2023-05-02 | — | — | US | disclosed |
| US-8748582-B2 | Affinity ligands and methods for protein purification | MONASH UNIVERSITY (AU) | 2014-06-10 | — | — | US | disclosed |
| US-20120259094-A1 | AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION | MONASH UNIVERSITY | 2012-10-11 | — | — | US | disclosed |
| US-8198364-B2 | Poly (vinyl alcohol) polymers, uses and preparation thereof | VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) | 2012-06-12 | — | — | US | disclosed |
| US-20100038297-A1 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof | UNIVERSITE DE MONTREAL (CA) | 2010-02-18 | — | — | US | disclosed |
| US-4364876-A | QUICK-SETTING ADHESIVES, COATINGS, MOLDING MATERIALS | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100038297-A1 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof | PUF60, VCL, PARG | HSD17B10 269/4885USP2 1852/4885HTT 3827/4885 |
| US-20120259094-A1 | AFFINITY LIGANDS AND METHODS FOR PROTEIN PURIFICATION | MAX, SPR, CCL2 | HSD17B10 4101/4885USP2 2808/4885HTT 3718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.